Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment

Mise à jour : Il y a 4 ans
Référence : NCT00087958

Femme et Homme

Extrait

The purpose of this clinical trial is to determine if the investigational drug is able to reduce/shrink advanced breast cancer tumors in patients who no longer benefit from anthracyclines, taxanes and capecitabine.


Critère d'inclusion

  • Breast Cancer


Liens